These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 17457930

  • 1. Liver transplantation for status 1: the consequences of good intentions.
    McDiarmid SV, Goodrich NP, Harper AM, Merion RM.
    Liver Transpl; 2007 May; 13(5):699-707. PubMed ID: 17457930
    [Abstract] [Full Text] [Related]

  • 2. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004).
    Shneider BL, Suchy FJ, Emre S.
    Liver Transpl; 2006 Jan; 12(1):40-5. PubMed ID: 16382460
    [Abstract] [Full Text] [Related]

  • 3. Regionwide sharing for status 1 liver patients--beneficial impact on waiting time and pre- and posttransplant survival.
    Humar A, Khwaja K, Glessing B, Larson E, Asolati M, Durand B, Lake J, Payne WD.
    Liver Transpl; 2004 May; 10(5):661-5. PubMed ID: 15108258
    [Abstract] [Full Text] [Related]

  • 4. Clinical characterization and survival of adult patients awaiting liver transplantation in Chile.
    Zapata R, Innocenti F, Sanhueza E, Humeres R, Rios H, Suarez L, Palacios JM, Rius M, Hepp J.
    Transplant Proc; 2004 May; 36(6):1669-70. PubMed ID: 15350446
    [Abstract] [Full Text] [Related]

  • 5. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics.
    Chungfat N, Dixler I, Cohran V, Buchman A, Abecassis M, Fryer J.
    J Am Coll Surg; 2007 Dec; 205(6):755-61. PubMed ID: 18035258
    [Abstract] [Full Text] [Related]

  • 6. Combined orthotopic heart and liver transplantation: the need for exception status listing.
    Porrett PM, Desai SS, Timmins KJ, Twomey CR, Sonnad SS, Olthoff KM.
    Liver Transpl; 2004 Dec; 10(12):1539-44. PubMed ID: 15558654
    [Abstract] [Full Text] [Related]

  • 7. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
    Winkel E, Kao W, Fisher SG, Heroux AL, Johnson MR, Costanzo MR.
    J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
    [Abstract] [Full Text] [Related]

  • 8. Referral patterns and waiting times for liver transplantation in Singapore.
    Lim SG, Wai CT, Da Costa M, Sutedja DS, Lee YM, Lee KH, Tan CK, Aw MM, Quak SH, Prabhakaran K, Tan KC, Isaac J.
    Singapore Med J; 2006 Jul; 47(7):599-603. PubMed ID: 16810432
    [Abstract] [Full Text] [Related]

  • 9. Mortality in candidates waiting for combined liver-intestine transplants exceeds that for other candidates waiting for liver transplants.
    Fryer J, Pellar S, Ormond D, Koffron A, Abecassis M.
    Liver Transpl; 2003 Jul; 9(7):748-53. PubMed ID: 12827564
    [Abstract] [Full Text] [Related]

  • 10. Deaths on the liver transplant waiting list: an analysis of competing risks.
    Kim WR, Therneau TM, Benson JT, Kremers WK, Rosen CB, Gores GJ, Dickson ER.
    Hepatology; 2006 Feb; 43(2):345-51. PubMed ID: 16440361
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation in New Zealand: the first four years.
    Gane E, McCall J, Streat S, Gunn K, Yeong ML, Fitt S, Keenan D, Munn S.
    N Z Med J; 2002 Aug 09; 115(1159):U120. PubMed ID: 12362165
    [Abstract] [Full Text] [Related]

  • 12. The UNOS OPTN (Organ Procurement and Transplantation Network) waiting list: 1988 through November 30, 1992.
    Edwards EB, Breen TJ, Guo T, Ellison MD, Daily OP.
    Clin Transpl; 1992 Aug 09; ():61-75. PubMed ID: 1306723
    [Abstract] [Full Text] [Related]

  • 13. Effect of body mass index on the survival benefit of liver transplantation.
    Pelletier SJ, Schaubel DE, Wei G, Englesbe MJ, Punch JD, Wolfe RA, Port FK, Merion RM.
    Liver Transpl; 2007 Dec 09; 13(12):1678-83. PubMed ID: 18044787
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for liver transplantation waiting list mortality.
    Fink MA, Berry SR, Gow PJ, Angus PW, Wang BZ, Muralidharan V, Christophi C, Jones RM.
    J Gastroenterol Hepatol; 2007 Jan 09; 22(1):119-24. PubMed ID: 17201891
    [Abstract] [Full Text] [Related]

  • 15. Is MELD score sufficient to predict not only death on waiting list, but also post-transplant survival?
    Silberhumer GR, Hetz H, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Soliman T, Steininger R, Muehlbacher F, Berlakovich GA.
    Transpl Int; 2006 Apr 09; 19(4):275-81. PubMed ID: 16573542
    [Abstract] [Full Text] [Related]

  • 16. Organ allocation in pediatric transplantation in France.
    Loirat C, Chalem Y, Golmard JL.
    Pediatr Nephrol; 2001 Dec 09; 16(12):964-70. PubMed ID: 11793081
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH, Hidalgo R, Thomé T, Melo VA, Lobue A, Zurstrassen MP, Moraes JM, Meira-Filho SP, Rezende MB, Fonseca LE, Pandullo FL, Soeiro FS, Afonso RC.
    Transplant Proc; 2007 Oct 09; 39(8):2511-3. PubMed ID: 17954160
    [Abstract] [Full Text] [Related]

  • 18. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality.
    Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R.
    Isr Med Assoc J; 2006 Sep 09; 8(9):605-9. PubMed ID: 17058408
    [Abstract] [Full Text] [Related]

  • 19. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
    Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA.
    Liver Transpl; 2009 Aug 09; 15(8):859-68. PubMed ID: 19642139
    [Abstract] [Full Text] [Related]

  • 20. Projected survival benefit as criterion for listing and organ allocation in heart transplantation.
    Krakauer H, Lin MJ, Bailey RC.
    J Heart Lung Transplant; 2005 Jun 09; 24(6):680-9. PubMed ID: 15949727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.